Get informed when a big investor buys or sells
+ FollowOvervalued by 45.8% based on the discounted cash flow analysis.
Loading insider trades…
Loading congress trades…
| Market cap | $6.57 Billion |
|---|---|
| Enterprise Value | $8.21 Billion |
| Annual dividend | $0.08 |
| Dividend yield | 2.16% |
| Earnings per Share | $0.09 |
| Beta | 0.92 |
| Outstanding Shares | 1,953,694,374 |
| P/E Ratio | 53.81 |
|---|---|
| PEG | -110.98 |
| Price to Sales | 1.61 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 1.7 |
| Enterprise Value to EBIT | 10.7 |
| Enterprise Value to Net Income | 24 |
| Total Debt to Enterprise | 0.21 |
| Debt to Equity | 1.22 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
ConvaTec Group Plc is a global medical technology company focused on creating, producing, and distributing a wide array of healthcare products. Their offerings span several key areas: Advanced Wound Management: This includes specialized ...